Tesamorelin 10mg
Metabolic
Overview
Tesamorelin 10mg is a synthetic growth hormone-releasing hormone (GHRH) analogue supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into peptide structure, receptor interaction, and signalling pathways.
Classification: Tesamorelin — a synthetic 44 amino-acid analogue of human growth hormone-releasing hormone (GHRH1–44), with an N-terminal trans-3-hexenoyl modification that increases enzymatic stability.
Research background
Within laboratory settings, Tesamorelin is studied for its interaction with growth hormone-releasing hormone (GHRH) receptors and associated endocrine signalling pathways. Research applications focus on receptor binding activity, peptide stability, and hormone pathway modelling under controlled experimental conditions.
This summary describes published preclinical and, where applicable, clinical research. It is not a medical claim and does not describe or endorse any human use of the compound as sold by Peptides UK 4U.
Mechanism of action (under investigation)
Tesamorelin is studied as a GHRH-receptor agonist that promotes pituitary somatotroph release of endogenous growth hormone. Published research examines its effects on the GH/IGF-1 axis and downstream metabolic parameters in preclinical and clinical settings.
Laboratory handling
Add 0.5ml of AA water until all powder is dissolved and then add 2.5ml of bac water, never shake.
Storage & stability
- Store in a cool, dry environment before reconstitution.
- For extended stability, storage at -20°C is recommended.
- Avoid repeated freeze-thaw cycles after reconstitution.
For reconstitution volumes and target working concentrations use our peptide calculator. We do not publish dosing protocols for human use.
Product specifications
- Peptide Type
- Synthetic GHRH analogue
- Scientific Name
- Tesamorelin acetate
- Form
- Lyophilised powder
- Quantity
- 10mg
- Purity
- ≥98% (subject to batch testing)
- Appearance
- White lyophilised powder
- Solubility
- Water soluble
- Stability
- Maintains integrity under controlled storage conditions
- Manufacturing Standard
- Produced in controlled laboratory environments
Certificate of Analysis: Available on request from our support team.
Frequently asked questions
What is Tesamorelin studied for in research?
Tesamorelin is a synthetic growth-hormone-releasing-hormone (GHRH) analogue investigated in vitro for its interaction with GHRH receptors and downstream endocrine signalling pathways.
What purity is your Tesamorelin?
Every 10mg vial is tested to ≥98% purity by RP-HPLC. A batch-specific Certificate of Analysis is available on request.
How is Tesamorelin reconstituted?
Tesamorelin requires an acetic-acid pre-solubilisation step before bacteriostatic water is added — swirl gently, never shake. See our peptide calculator for target concentrations and volumes.
How stable is reconstituted Tesamorelin?
Reconstituted Tesamorelin should be refrigerated at 2–8°C, protected from light, and used within the standard 28-day window for GHRH-family peptides.
References
- Ferdinandi ES et al., Basic & Clinical Pharmacology & Toxicology 100(1):49–58 (2007) — tesamorelin pharmacology
- Falutz J et al., NEJM 357(23):2359–2370 (2007) — GHRH analogue clinical research
References are provided for educational context. Citation does not imply endorsement of any specific use.
Disclaimer: This article is provided for laboratory and educational purposes only. It is not medical advice and does not describe or endorse any human use. All products sold by Peptides UK 4U are for laboratory research only, are not for human or veterinary consumption, and are not intended to diagnose, treat, cure or prevent any disease.